HAE
Haemonetics Corp.

635
Mkt Cap
$3.52B
Volume
738,887.00
52W High
$89.69
52W Low
$47.32
PE Ratio
21.94
HAE Fundamentals
Price
$75.12
Prev Close
$75.19
Open
$75.19
50D MA
$54.62
Beta
0.69
Avg. Volume
644,822.78
EPS (Annual)
$3.31
P/B
4.14
Rev/Employee
$450,156.80
Loading...
Loading...
News
all
press releases
Intech Investment Management LLC Has $2.61 Million Position in Haemonetics Corporation $HAE
Intech Investment Management LLC lessened its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 23.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Interpreting Haemonetics (HAE) International Revenue Trends
Review Haemonetics' (HAE) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Zacks·3d ago
News Placeholder
Haemonetics Corporation $HAE Stake Boosted by SG Capital Management LLC
SG Capital Management LLC grew its holdings in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 92.5% during the second quarter, according to the company in its most recent filing with...
MarketBeat·4d ago
News Placeholder
Here's Why Haemonetics (HAE) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·6d ago
News Placeholder
Boston Partners Acquires 11,738 Shares of Haemonetics Corporation $HAE
Boston Partners raised its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 2.2% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 543,169...
MarketBeat·6d ago
News Placeholder
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·7d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Has $13 Million Stake in Haemonetics Corporation $HAE
Connor Clark & Lunn Investment Management Ltd. reduced its position in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 22.3% in the 2nd quarter, according to the company in its most...
MarketBeat·9d ago
News Placeholder
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·9d ago
News Placeholder
Haemonetics Corporation (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Haemonetics Corporation (NYSE:HAE - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve ratings firms that are presently covering the company, Marketbeat Ratings...
MarketBeat·10d ago
News Placeholder
Haemonetics (NYSE:HAE) Posts Quarterly Earnings Results, Beats Estimates By $0.15 EPS
Haemonetics (NYSE:HAE - Get Free Report) released its quarterly earnings results on Thursday. The medical instruments supplier reported $1.27 EPS for the quarter, beating the consensus estimate of...
MarketBeat·11d ago

Latest HAE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.